Mayo Clinic proceedings
-
Statins are the mainstay of cholesterol treatment to prevent atherosclerotic cardiovascular disease. However, significant barriers, including physician and patient factors, prevent the optimal use of this drug class. ⋯ Within the tips, we discuss key components of the guidelines, assessing cardiovascular risk profiles, evaluating drug-drug interactions, addressing adverse effects, and developing treatment plans that include statins and nonstatins. The tips will be useful for primary and specialty clinicians, such as cardiologists, endocrinologists, and nephrologists.
-
Mayo Clinic proceedings · Dec 2024
ReviewPost-Pulmonary Embolism Syndrome-A Diagnostic Dilemma and Challenging Management.
Historically, research on pulmonary embolism (PE) management has focused on short-term outcomes, such as acute cardiovascular collapse, change in right ventricular function, and in-hospital mortality. However, long-standing functional impairments from acute PE occur in up to half of all patients. ⋯ This review seeks to increase awareness of the syndrome that affects a significant portion of PE survivors. The epidemiology, pathophysiology, and clinical features are discussed, followed by a description of imaging findings and management options across the entire spectrum of post-PE syndrome.
-
Mayo Clinic proceedings · Dec 2024
Multicenter StudyPatient Perceptions of East and Southeast Asian Physicians Amidst Anti-Asian Rhetoric During the COVID-19 Pandemic.
To examine the effects of anti-Asian rhetoric on how patients perceive East/Southeast Asian physicians. This study examines changes in patient satisfaction scores of East/Southeast Asian physicians in a multisite health system following the onset of the COVID-19 pandemic. ⋯ These findings contribute to the growing literature on the experience of Asian health care workers in the United States and highlight the need for further investigation into the experiences of physicians of color during the volatility of the pandemic.